The statutory authority permitting other than full and open competition is 41 U.S.C. 253(c)(1) as cited in FAR 6.302-1, "Only one responsible source and no other supplies or services will satisfy agency requirements." Medimmune, LLC, is the only contractor that can perform these services due to their unique position as the manufacturer of the vaccinations. In order to assure the maximum available shelf-life for CDC's vaccines, the vaccines must remain in the possession of the manufactuer to be rotated on a First-In, First-Out basis with vaccines Medimmune is currently producing. Further, if the vaccines leave the possession of the manufacturer, Medimmune will no longer accept the vaccines into their inventory, and thus the vaccines will have a shorter shelf-life than a constantly rotated stockpile maintained by the manufacturer. The goal is to maintain a minimum shelf-life of 6 months on all influenza vaccines in order to ensure readiness to deploy the stockpile for disease response. As the manufacturer, Medimmune is the only vendor with a market large enough to produce, replace, and rotate the stockpiled vaccines in combination with their operating inventory to maintain a viable stockpile.

Responsible sources that believe they possess the expertise and capabilities identified above are encouraged to submit to the Contracting Officer within 10 days from the posting date of this notice, their written capabilities statement, proposal or quotation which shall be considered by the agency. Please forward the capability statement and/or pricing information to David Dombeck, Contracting Specialist, Reference 2013-64498, Centers for Disease Control, Procurement and Grants Office, ATTN: David Dombeck, MS: K-14, 2920 Brandywine Road, Atlanta, GA 30341. All vendors must be registered in the System for Award Management (SAM) prior to an award of a federal contract. The website is: www.sam.gov.

The Government will review any/all capabilities statements and pricing information submitted and determine if other qualified sources do exist that could provide this requirement. Information received in response to this announcement will be used solely for the purpose of determining whether to conduct a competitive procurement.

If no affirmative responses are received within 10 days, negotiations will be conducted with the Medimmune, as the only source and a contract will be issued without any additional notices being posted.